Mirion Technologies (MIR) Goldman Sachs Industrials and Materials Conference summary
Event summary combining transcript, slides, and related documents.
Goldman Sachs Industrials and Materials Conference summary
8 Jul, 2026Business overview and market positioning
Holds a unique leadership position in ionizing radiation detection, measurement, and analysis, leading 17 of 19 global product categories.
Technology is leveraged across medical, nuclear, and safety segments, enabling scalable growth without losing focus.
Two-thirds of revenue comes from nuclear and safety, with the remainder from medical applications.
Nuclear and safety segment insights
Nuclear power represents 60% of the nuclear and safety segment, with strong exposure to the global nuclear renaissance.
Present in over 95% of operating nuclear reactors worldwide, participating throughout the plant lifecycle.
80% of nuclear revenue is recurring, driven by the installed base and a defensible competitive moat.
Industry tailwinds include decarbonization, energy security, and increased demand from AI and electrification.
Operators are shifting to expansionary modes, increasing replacement cycles and discretionary spending.
Growth drivers and regional opportunities
Utility-scale new build pipeline is robust, with significant activity in Europe, North Africa, the Gulf, Korea, and India.
Strategic partnerships, such as with EDF and ECIL, provide sole-source agreements and margin expansion opportunities.
SMR (small modular reactor) market is emerging, with higher revenue per megawatt than utility-scale reactors.
Workforce demographic shifts are driving digitization and increased demand for digital service offerings.
Latest events from Mirion Technologies
- Q2 2026 revenue up 19.7%, adjusted EBITDA up 27.5%, and guidance reaffirmed.MIR
Q2 2026 - All proposals passed, directors elected, and no questions raised during the annual meeting.MIR
AGM 2026 - Revenue up 27.6% to $257.6M, backlog at $1.1B, and 2026 guidance reaffirmed.MIR
Q1 2026 - Key votes include board elections, auditor ratification, and executive pay approval.MIR
Proxy filing - Record orders, strong growth, and enhanced governance mark a transformative year.MIR
Proxy filing - Record orders and margin expansion in 2025 set the stage for double-digit growth in 2026.MIR
Q4 2025 - Q3 2025 saw strong revenue, profit, and cash flow growth, with major nuclear wins and financings.MIR
Q3 2025 - Q1 2025 saw 6% organic growth, 18% EBITDA rise, margin expansion, and raised guidance.MIR
Q1 2025 - Record 2024 results, margin expansion, and strong 2025 outlook with robust backlog and cash flow.MIR
Q4 2024